|
A
|
LVMI
|
RWT
|
LVEDD
|
LVEF
|
RVEDD
|
|---|
|
FABP 4 overall
|
|
R
|
− 0.25
|
0.15
|
− 0.20
|
0.09
|
0.03
|
|
p-value
|
< 0.001
|
0.006
|
< 0.001
|
0.104
|
0.568
|
|
FABP 4 women
|
|
R
|
− 0.16
|
0.18
|
− 0.05
|
0.12
|
0.22
|
|
p-value
|
0.136
|
0.076
|
0.661
|
0.243
|
0.032
|
|
FABP 4 men
|
|
R
|
− 0.17
|
0.21
|
− 0.12
|
0.04
|
0.08
|
|
p-value
|
0.008
|
< 0.001
|
0.068
|
0.588
|
0.211
|
|
B
|
Nt-proBNP
|
Hs-cTnT
|
eGFR
|
age
|
BMI
|
|---|
|
FABP 4 overall
|
|
R
|
0.35
|
0.35
|
0.36
|
− 0.48
|
0.29
|
|
p-value
|
< 0.001
|
< 0.001
|
< 0.001
|
< 0.001
|
< 0.001
|
|
FABP 4 women
|
|
R
|
0.18
|
0.18
|
0.46
|
−0.39
|
0.28
|
|
p-value
|
0.093
|
0.093
|
< 0.001
|
< 0.001
|
0.007
|
|
FABP 4 men
|
|
R
|
0.40
|
0.40
|
0.42
|
− 0.51
|
0.30
|
|
p-value
|
< 0.001
|
< 0.001
|
< 0.001
|
< 0.001
|
< 0.001
|
- Spearman Rank correlation analyses between FABP4 and CMR measures (A) and laboratory results, age, and body mass index (B) overall, in men, and in women
- Italic values indicate statistically significant correlations, p-value < 0.05
- BMI, body mass index; eGFR, estimated glomerular filtration rate; FABP4, Fatty-acid binding protein 4; hs-cTnT, cardiac high sensitivity troponin T; LVEDD, left ventricular end-diastolic diameter; LVEF, left ventricular ejection fraction; LVMI, left ventricular mass index; NT-proBNP, N-terminal pro B-type brain natriuretic peptid; RVEDD, right ventricular end-diastolic diameter; RWT, relative wall thickness
